YM-355179 (fumarate)
YM-355179 fumarate is a newly synthesized selective CCR3 antagonist with the potential to inhibit eosinophil-related allergic inflammatory diseases. YM-355179 can effectively inhibit the binding of CCL11 and CCL5 to CCR3-expressing cells, with IC50 values of 7.6 nM and 24 nM respectively. In functional experiments, YM-355179 can inhibit CCL11-induced intracellular Ca (2+) influx, chemotaxis and eosinophil degranulation, IC50 The values are 8.0 nM, 24 nM and 29 nM respectively[1].
Product Specifications
CAS Number
[887647-69-0]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ym-355179-fumarate.html
Smiles
O=C(N[C@H]1CN(CC2=CC=C3C=C(F)C=CC3=C2)CC1)/C=C4CCN(C(C5=NC=C(C)C=C5O)=O)CC\4.O=C(O)/C=C/C(O)=O
Molecular Formula
C33H35FN4O7
Molecular Weight
618.65
References & Citations
[1]A novel, selective, and orally available antagonist for CC chemokine receptor 3
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Recombinant Myosin Heavy Chain 14, Non Muscle (MYH14)
Recombinant Myosin Heavy Chain 14, Non Muscle (MYH14)
Recombinant Myosin Heavy Chain 14, Non Muscle (MYH14)
Recombinant Myosin Heavy Chain 14, Non Muscle (MYH14)
